TILRAY INC

NASDAQ: TLRY (Tilray Brands, Inc.)

Last update: 07 Aug, 7:50PM

0.651

0.03 (5.40%)

Previous Close 0.617
Open 0.625
Volume 15,398,258
Avg. Volume (3M) 33,072,217
Market Cap 714,593,792
Price / Sales 1.59
Price / Book 1.07
52 Weeks Range
0.350 (-46%) — 1.98 (204%)
Earnings Date 9 Oct 2025
Profit Margin -114.40%
Operating Margin (TTM) -16.76%
Diluted EPS (TTM) -1.10
Quarterly Revenue Growth (YOY) -1.40%
Total Debt/Equity (MRQ) 12.73%
Current Ratio (MRQ) 2.62
Operating Cash Flow (TTM) -51.09 M
Levered Free Cash Flow (TTM) 26.37 M
Return on Assets (TTM) -1.63%
Return on Equity (TTM) -30.73%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Bullish Mixed
Drug Manufacturers - Specialty & Generic (Global) Bullish Mixed
Stock Tilray Brands, Inc. Bullish Mixed

AIStockmoo Score

0.0
Analyst Consensus 1.5
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages -1.5
Technical Oscillators 2.0
Average 0.00

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
TLRY 715 M - - 1.07
RGC 7 B - - 1.03
INDV 3 B - 28.96 145.25
ANIP 2 B - - 4.59
BGM 2 B - - 8.92
PCRX 1 B - - 1.59

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Value
% Held by Insiders 0.69%
% Held by Institutions 10.10%
52 Weeks Range
0.350 (-46%) — 1.98 (204%)
Median 2.00 (207.46%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
Jefferies 25 Aug 2025 2.00 (207.46%) Buy 1.39

No data within this time range.

Date Type Details
28 Aug 2025 Announcement Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains
28 Aug 2025 Announcement Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains
27 Aug 2025 Announcement Tilray Brands Successfully Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
21 Aug 2025 Announcement Unleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused Elixir
14 Aug 2025 Announcement Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements
13 Aug 2025 Announcement Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
13 Aug 2025 Announcement Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
12 Aug 2025 Announcement Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane’s and Happy Flower Brands
07 Aug 2025 Announcement Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at Whole Foods Market
28 Jul 2025 Announcement Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results
17 Jul 2025 Announcement Breckenridge Distillery Launches Mock One: Bold, Premium Non-Alcoholic Alternatives to Whiskey, Tequila, Gin & Rum - Crafted for Everyone Who Loves a Great Drink
09 Jul 2025 Announcement Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025
01 Jul 2025 Announcement Beers, Live Music, Hot Dogs and Fireworks: Everything You Need for an Epic 4th Of July Celebration
01 Jul 2025 Announcement Breckenridge Distillery Unveils Limited-Edition Collectors Art Series Collaboration with Renowned Artist Miles Toland
26 Jun 2025 Announcement Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation
26 Jun 2025 Announcement Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations
26 Jun 2025 Announcement Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations
24 Jun 2025 Announcement Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use
24 Jun 2025 Announcement Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use
23 Jun 2025 Announcement Elevate Your Summer with Canada’s Leading Cannabis Brands and Products by Tilray Brands
10 Jun 2025 Announcement Manitoba Harvest and Whole Foods Market Collaborate to Launch New Protein-Packed, Hemp+ Superfood Smoothie Boosters
10 Jun 2025 Announcement Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price
05 Jun 2025 Announcement Attention Craft Beer Fans! Tilray Beverages Highlights Boldest Brews For Summer
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria